47.73.Z - Retail sale of pharmaceutical products
47.61.Z - Retail sale of books
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
73.12.D - Advertising through mass media
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,4 | 1,6 | 1,9 | 14,8 |
Gross profit (loss) | 1,4 | 1,7 | 1,9 | 13,7 |
EBITDA | 1,5 | 1,8 | 2 | 13,5 |
Short time liabilities | 1,7 | 1,3 | 2,1 | 55,1 |
Other operating costs | 0,1 | 0,1 | 0,1 | -8,8 |
Equity capital | 2,8 | 2,9 | 3,2 | 8,9 |
Operating profit (EBIT) | 1,4 | 1,7 | 1,9 | 13,4 |
Assets | 4,7 | 4,4 | 5,5 | 23,4 |
Net profit (loss) | 1,4 | 1,7 | 1,9 | 13,7 |
Cash | 2 | 1,3 | 2,3 | 78,1 |
Net income from sale | 12,6 | 14 | 15,4 | 9,9 |
Liabilities and provisions for liabilities | 2 | 1,5 | 2,3 | 51,3 |
Working assets | 4,2 | 4 | 5 | 24,8 |
Other income costs | 0,1 | 0,1 | 0,1 | -24,2 |
Depreciation | 0,1 | 0,1 | 0,1 | 15,7 |
% | % | % | p.p. | |
Profitability of capital | 52,2 | 57 | 59,5 | 2,5 |
Equity capital to total assets | 58,7 | 65,8 | 58,1 | -7,7 |
Gross profit margin | 11,5 | 11,8 | 12,2 | 0,4 |
EBITDA Margin | 12,2 | 12,5 | 12,9 | 0,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 51 | 35 | 49 | 14 |
Current financial liquidity indicator | 2.428253173828125 | 2.9800498485565186 | 2.3982479572296143 | -0,6 |
Net dept to EBITDA | -1.2742308378219604 | -0.7268149852752686 | -1.1398895978927612 | -0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane